Legal & General Group Plc - PRELUDE THERAPEUTICS INC ownership

PRELUDE THERAPEUTICS INC's ticker is PRLD and the CUSIP is 74065P101. A total of 61 filers reported holding PRELUDE THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 6.00 and the average weighting 0.0%.

Quarter-by-quarter ownership
Legal & General Group Plc ownership history of PRELUDE THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$2,973
-31.3%
9620.0%0.00%
Q2 2023$4,329
-84.0%
962
-75.4%
0.00%
Q1 2022$27,000
-44.9%
3,9140.0%0.00%
Q4 2021$49,000
-46.7%
3,914
+32.3%
0.00%
Q3 2021$92,000
+187.5%
2,958
+164.8%
0.00%
Q2 2021$32,000
-28.9%
1,117
+6.6%
0.00%
Q1 2021$45,000
-37.5%
1,048
+4.4%
0.00%
Q4 2020$72,000
-96.1%
1,004
-98.4%
0.00%
-100.0%
Q3 2020$1,853,00061,4890.00%
Other shareholders
PRELUDE THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Orbimed Advisors 10,039,691$313,740,0003.45%
Baker Brothers Advisors 10,123,824$316,370,0001.39%
Logos Global Management LP 400,000$12,500,0000.90%
HHLR ADVISORS, LTD. 583,333$18,229,0000.24%
Rock Springs Capital Management LP 362,359$11,324,0000.24%
Virtus ETF Advisers LLC 6,292$197,0000.09%
FEDERATED HERMES, INC. 408,100$12,753,0000.02%
Virtu Financial LLC 7,940$248,0000.02%
UBS ASSET MANAGEMENT AMERICAS LLC 1,483,319$46,353,719,0000.02%
FMR LLC 7,055,666$220,489,0000.02%
View complete list of PRELUDE THERAPEUTICS INC shareholders